HF
QNCX icon

HRT Financial’s Quince Therapeutics QNCX Stock Holding History

HRT Financial’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-73
Closed -$19K – 3375
2025
Q1 		$19K Sell
73
-28
-28% -$8.55K ﹤0.01% 2308
2024
Q4 		$37K Buy
+101
New +$30.3K ﹤0.01% 2138
2021
Q4 		– Sell
-72
Closed -$1.31M – 3903
2021
Q3 		$1.31M Buy
+72
New +$1.15M 0.01% 1044

Other funds holding QNCX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

HRT Financial's QNCX Position: Q2 2025 in Review

HRT Financial sold out of Quince Therapeutics (QNCX) in Q2 2025, closing a stake of 73 shares — an estimated $19K sold.

HRT Financial first reported a position in QNCX in Q3 2021 and held it in 3 quarters. The position peaked at $1.31M in Q3 2021. 37 funds tracked by Wall St. Rank hold QNCX as of Q2 2025.

  • HRT Financial reported no remaining Quince Therapeutics position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 73 Quince Therapeutics shares in Q2 2025, an estimated $19K.
  • HRT Financial first reported a position in Quince Therapeutics in Q3 2021 and held it in 3 quarters.
  • HRT Financial's Quince Therapeutics position peaked at $1.31M in Q3 2021.
  • 37 funds tracked by Wall St. Rank held Quince Therapeutics as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.